Clinical Trial Update: Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating sotorasib in healthy participants and those with moderate to severe hepatic impairment has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment Effect On Drug Pharmacokinetics

Drugs mentioned

• sotorasib (sotorasib)

Snippet

Sponsor: Amgen | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2024-04-19